PCRX ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Pacira BioSciences, Inc.
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into Pacira BioSciences, Inc. for potential securities fraud violations. This follows a press release by Pacira on August 9, 2024, regarding a lawsuit outcome against eVenus for patent infringement.
December 04, 2024 | 12:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Pacira BioSciences is under investigation by Levi & Korsinsky for potential securities fraud violations. This could impact investor confidence and stock price.
The investigation into potential securities fraud violations could lead to legal challenges and affect investor confidence, likely causing a negative impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100